DK0512883T3 - Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse - Google Patents

Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse

Info

Publication number
DK0512883T3
DK0512883T3 DK92401157.0T DK92401157T DK0512883T3 DK 0512883 T3 DK0512883 T3 DK 0512883T3 DK 92401157 T DK92401157 T DK 92401157T DK 0512883 T3 DK0512883 T3 DK 0512883T3
Authority
DK
Denmark
Prior art keywords
concentrate
specific activity
high specific
therapeutic use
preparing
Prior art date
Application number
DK92401157.0T
Other languages
English (en)
Inventor
Nee Radosevich Miryana Burnouf
Dominique Dernis
Original Assignee
Ass Pour Lessor De La Transfus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ass Pour Lessor De La Transfus filed Critical Ass Pour Lessor De La Transfus
Application granted granted Critical
Publication of DK0512883T3 publication Critical patent/DK0512883T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6443Coagulation factor XIa (3.4.21.27)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21027Coagulation factor XIa (3.4.21.27)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK92401157.0T 1991-05-07 1992-04-23 Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse DK0512883T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105572A FR2676231A1 (fr) 1991-05-07 1991-05-07 Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.

Publications (1)

Publication Number Publication Date
DK0512883T3 true DK0512883T3 (da) 1998-03-16

Family

ID=9412593

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92401157.0T DK0512883T3 (da) 1991-05-07 1992-04-23 Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse

Country Status (16)

Country Link
US (1) US5252217A (da)
EP (1) EP0512883B1 (da)
AT (1) ATE156360T1 (da)
AU (1) AU652043B2 (da)
BR (1) BR9201718A (da)
CA (1) CA2068069C (da)
DE (1) DE69221369T2 (da)
DK (1) DK0512883T3 (da)
EE (1) EE03017B1 (da)
ES (1) ES2107511T3 (da)
FR (1) FR2676231A1 (da)
GR (1) GR3025134T3 (da)
IL (1) IL99567A (da)
LT (1) LT3417B (da)
RU (1) RU2097047C1 (da)
UA (1) UA27733C2 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
RU2298416C2 (ru) * 2001-07-20 2007-05-10 Ново Нордиск Хелт Кэр Аг Фармацевтическая композиция, содержащая полипептиды фактора vii и полипептиды фактора xi
JP2007513881A (ja) * 2003-11-20 2007-05-31 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト Xi因子の治療学的使用
US20050181978A1 (en) * 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
CN101511387A (zh) * 2006-09-08 2009-08-19 惠氏公司 使用亲和色谱法纯化蛋白质的精氨酸洗涤液
DK2102335T3 (da) * 2007-01-04 2012-05-07 Crucell Holland Bv Rensning af faktor XI
NZ592203A (en) * 2008-10-15 2013-01-25 Isis Pharmaceuticals Inc Modulation of factor 11 expression
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2974366B1 (fr) * 2011-04-20 2016-06-24 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur xi
IL212911A0 (en) 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
DE102012022234A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen
DE102012022233A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Verfahren zur Reinigung eines (Blut)plasmaproteins
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
BR112020020957B1 (pt) 2018-05-09 2022-05-10 Ionis Pharmaceuticals, Inc Compostos oligoméricos, população e composição farmacêutica dos mesmos e seus usos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
US4783262A (en) * 1987-03-30 1988-11-08 Cuno Incorporated Separator for cell type filter element

Also Published As

Publication number Publication date
AU1526392A (en) 1992-11-12
EE03017B1 (et) 1997-08-15
EP0512883B1 (fr) 1997-08-06
EP0512883A1 (fr) 1992-11-11
DE69221369T2 (de) 1998-03-19
LT3417B (en) 1995-09-25
FR2676231A1 (fr) 1992-11-13
US5252217A (en) 1993-10-12
LTIP265A (en) 1994-10-25
CA2068069A1 (en) 1992-11-08
DE69221369D1 (de) 1997-09-11
ES2107511T3 (es) 1997-12-01
IL99567A0 (en) 1992-08-18
CA2068069C (en) 2005-03-15
RU2097047C1 (ru) 1997-11-27
FR2676231B1 (da) 1995-04-21
IL99567A (en) 1996-01-19
BR9201718A (pt) 1992-12-29
AU652043B2 (en) 1994-08-11
UA27733C2 (uk) 2000-10-16
GR3025134T3 (en) 1998-02-27
ATE156360T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
DK184186A (da) Terapeutisk praeparat til behandling af virussygdomme
DK161426C (da) Medicinsk apparat til stimulering af blodcirkulation i en persons fod
FI872756A0 (fi) Med laserstraolning fungerande terapeutisk anordning.
DK322189A (da) Imidazo(1,2-a)-(pyridaziner eller pyraziner) til behandling af sygdomme med relation til knogletab
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
AU7426487A (en) Method of treating depression using d-fenfluramine
DK93390D0 (da) Ufuldstaendige hepadnavira og cellelinie, der producerer vacciner, samt behandling af leversygdomme og -forstyrrelser
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
EP0212310A3 (en) Use of probucol in the preparation of a medicament for the treatment of heart arrhythmia
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.
ZA86101B (en) Process for recovering absorbent for use in extracorporeal circulation treatment
DK236489D0 (da) Anvendelse af diazepinoner til terapeutisk behandling af mikrokredsloebsforstyrrelser
DK72088A (da) Oximethere af 2,6-dioxabicyclo(3.3.0)octanoner og farmaceutiske praeparater til behandling af hjerte- og blodkredsloebssygdomme
DK0385422T3 (da) 1,4-Dihydro-5-isopropoxy-2-methyl-4-(2-trifluormethylphenyl)-1,6-naphthyridin-3-carboxylsyre-(-(N-methyl-N-phenylmethylamino)ethyl)ester-fumarat
ITMI941157A0 (it) Apparato magnetoterapico per la riattivazione della circolazione sanguigna per il lenimento di mialgie, dolori articolari per la cura di traumi muscolari o simili
RO82337A2 (ro) Bomboane medicinale pentru tratamentul afectiunilor buco-faringiene la copii
IT1247488B (it) Uso del pirrolidoncarbossilato di piridossina per il trattamento dei disturbi affettivi depressivi